Physician profile
Randolph R Rough
NPI 1376525196
$3,082.63
in general payments reported to CMS, 2019-2025
17 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $37.64 · 2021: $325 · 2022: $485 · 2023: $1,103 · 2024: $401 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $987.03 | 2021-2025 | Tyvaso, Remodulin |
| Actelion Pharmaceuticals US, INC. | $561.82 | 2019-2024 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $510.06 | 2022-2025 | Camzyos |
| Heartflow, INC. | $242.39 | 2022-2025 | Ffrct |
| Impulse Dynamics (USA) INC. | $188.12 | 2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $157.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.46 | 2021 | |
| Philips North America LLC | $70.93 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $59.52 | 2023 | Arcalyst |
| Boston Scientific Corporation | $59.36 | 2022-2024 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $42.90 | 2019 | |
| Medtronic Vascular, INC. | $16.75 | 2019 | |
| Abbott Laboratories | $13.91 | 2025 | Cardiomems |
| Lantheus Medical Imaging, INC. | $13.71 | 2020 | |
| Amgen INC. | $12.89 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11.04 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Rough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.